WHO ICTRP trial
A clinical study to Evaluate the Safety of stem cells in subjects with Type 1…
CTRI/2017/12/010878 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2017/12/010878 |
|---|---|
| Public title | A clinical study to Evaluate the Safety of stem cells in subjects with Type 1 diabetes |
| Scientific title | A Prospective, Randomized, Multi-Centric, Comparative, Open Label, Double arm Controlled Clinical Study to Evaluate the Safety of UCMSCs in subjects with recently diagnosed Type 1 diabetes |
| Primary sponsor | Reliance Life Sciences |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | India |
| Conditions | Health Condition 1: null- Subject must have a diagnosis of type 1 diabetes mellitus based on the American Diabetes Association (ADA) criteria Health Condition 2: E109- Type 1 diabetes mellitus without complications |
| Interventions | Intervention1: R-HSC-012: UCMSCs Control Intervention1: Standard Care of Treatment: Standard Care of Treatment for Type 1 Diabetes |
| Registration date | Dec 14, 2017 |
| Target size | 50 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: